drugset / Trial / NCT01298505
A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study in heathy people is to investigate the safety, toleration and time course of PF-03654764 in the blood, following multiple doses given by mouth together with fexofenadine.
Timeline
- Start
- 2010-06-04
- Primary completion
- 2010-06-04
- Completion
- 2010-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03654764 | Small molecule | 2.5 mg | Oral |
| Subject | PF-03654764 | Small molecule | 5 mg | Oral |
| Background | Fexofenadine | Unknown | 60 mg | Oral |
Indications
No indication recorded.